Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care-Reference-Cited by-同舟云学术

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care

Published:2019-06-06 Issue:7 Volume:21 Page:991-1001
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Pecoits‐Filho Roberto¹²,Fliser Danilo³,Tu Charlotte²,Zee Jarcy²,Bieber Brian²,Wong Michelle M. Y.²⁴,Port Friedrich²⁵,Combe Christian⁶,Lopes Antonio A.⁷,Reichel Helmut⁸,Narita Ichiei⁹,Stengel Benedicte¹⁰,Robinson Bruce M.²,Massy Ziad¹⁰¹¹,Duttlinger Christian,Duttlinger Johannes,Lonnemann Gerhard,Wada Takashi,Yamagata Kunihiro,Pisoni Ron,Calice da Silva Viviane,Sesso Ricardo,Speyer Elodie,Asahi Koichi,Hoshino Junichi,Perlman Rachel,Sukul Nidhi,Young Eric,

Affiliation:

1. School of Medicine Pontificia Universidade Catolica do Parana Curitiba Brazil

2. Arbor Research Collaborative for Health Ann Arbor Michigan

3. Department of Internal Medicine IV Saarland University Medical Center Homburg Germany

4. Department of Medicine University of British Columbia Vancouver Canada

5. Department of Internal Medicine, Michigan Medicine, and Department of Epidemiology, School of Public Health University of Michigan Ann Arbor Michigan

6. Service de Néphrologie Transplantation Dialyse Centre Hospitalier Universitaire de Bordeaux Bordeaux France

7. Faculdade de Medicina da Bahia School of Medicine Universidade Federal da Bahia Brazil

8. Nephrological Center Villingen‐Schwenningen Germany

9. Division of Clinical Nephrology and Rheumatology Niigata University Graduate School of Medical and Dental Science Niigata Japan

10. CESP, Center for Research in Epidemiology and Population Health University Paris‐Saclay, University Paris‐Sud, UVSQ Villejuif France

11. Division of Nephrology Ambroise Paré University Hospital, APHP Boulogne Billancourt/Paris France

Funder

National Health and Medical Research Council

Cancer Care Ontario

Institut National de la Santé et de la Recherche Médicale

Thailand Research Fund

King Chulalongkorn Memorial Hospital

National Research Council of Thailand

National Institute for Health Research

Agence Nationale de la Recherche

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.13563

Reference16 articles.

1. Clinical practice guideline for the management of blood pressure in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Workgroup;Kidney Int,2012

2. SkolnikN JohnsonEL.Clinical guidelines: ADA 2017 standards of medical care in diabetes. Family Practice News 2017.https://www.mdedge.com/familypracticenews/article/130408/diabetes/clinical-guidelines-ada-2017-standards-medical-care. Accessed 7/12/18.

3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

4. Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors

5. Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study;Journal of Nephrology;2024-02-06

2. Risk of Kidney Failure and Mortality in Patients Under Nephrology Care in NonHigh-Income Settings;Kidney International Reports;2024-02

3. Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex;Journal of General Internal Medicine;2023-12-14

4. Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD;American Journal of Kidney Diseases;2023-11

5. Hyperkalemia in CKD: an overview of available therapeutic strategies;Frontiers in Medicine;2023-07-31